Top 5 Medical Stocks To Watch For 2018

QIm now on Medicare, but I had opened a health savings account when I was still working and was covered by a high-deductible health insurance policy. Can I transfer funds from a traditional IRA to a health savings account now? How much can be transferred?

SEE ALSO: 10 Things Boomers Must Know About RMDs From IRAs
A

You can only transfer money from an IRA to an HSA if youre eligible to make new HSA contributions. Because youve enrolled in Medicare, you can no longer contribute to your HSA, although you can use the money in the account tax-free for eligible medical expenses. And now that youre over 65, these expenses include Medicare parts B and D as well as Medicare Advantage premiums.

People who still qualify to make HSA contributions can make a one-time rollover from an IRA to an HSA, which can be a good way to build up the account if you dont have other cash to contribute. You must currently have an HSA-eligible health insurance policy with a deductible of at least $1,300 for single coverage or $2,600 for family coverage. The amount you can roll over is the same as your annual HSA contribution limit — up to $3,400 in 2017 if you have single coverage or $6,750 if you have family coverage, plus an extra $1,000 if youre 55 or older. The annual contribution limit is the same, whether the money is coming from cash or an IRA rollover or a combination of the two.

Top 5 Medical Stocks To Watch For 2018: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Keith Speights]

    In October 2017, I predicted that Insys Therapeutics (NASDAQ:INSY) could be the biggest comeback story of 2018.For a while, it looked like I was on the right track. Insys stock soared in the fourth quarter of 2017. By early January, it was one of the hottest marijuana stocks on the market. Then the momentum evaporated.

  • [By Casey Wilson]

    Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.

  • [By ]

    Abbvie Inc. (ABBV) , for example, is generally just a pharmaceutical stock. However, the company also marketed Marinol, an FDA-approved synthetic cannabinoid meant to help nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY) is a pharmaceutical company that got approval from the U.S. Drug Enforcement Administration (DEA) for a synthetic cannabis – despite having donated to anti-marijuana advocacy groups in the past.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Insys Therapeutics (INSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks To Watch For 2018: Credit Suisse Group(CS)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    FAANG stocks are attempting to rebound today after a brutal sell-off hit the Nasdaq components Tuesday. The social media giant Facebook Inc. (Nasdaq: FB) will report earnings after the bell, but it’s likely that analysts are more interested in the company’s ongoing response to a data scandal that rocked investor sentiment and spurred privacy fears during the first quarter. Wall Street forecasts EPS of $1.36 on top of $11.45 billion in revenue.
    Right now, the 10-year interest rate is sitting on the border of 3%. And this news has many investors jittery about the impact on the stock market and the broader economy. Of course, many people forget that interest rates remain historically low for this stage of an economic expansion. And inflation targets remain stubbornly elusive for members of the U.S. Federal Reserve. The truth is that investors have little to worry about regarding interest rates. Instead, they should listen to Money Morning Chief Investment Strategist Keith Fitz-Gerald, who offered his insight to Fox Business Network earlier this week. Here’s what Keith had to say.
    Three Stocks to Watch Today: TWTR, CS, GE
    General Electric Co. (NYSE: GE) is under pressure to fire its auditor of 109 years, KPMG (for perspective, GE began its longtime relationship with KPMG a year after the first Model-T was built). Shareholder rights firms Glass-Lewis and Institutional Shareholder Services are spearheading the change and will push for adjustments during the firm’s annual shareholder meeting. The move comes after a calamitous year for GE, which saw the company become the worst-performing Dow component of 2017.
    Twitter Inc. (NYSE TWTR) will lead a very busy day of earnings reports. The social media giant is expected to report EPS of $0.12 on top of $609.8 million in revenue.
    Shares inCredit Suisse(ADR) (NYSE: CS) rallied more than 4% today after the Swiss financial giant beat earnings expectations before the bell. This was a significant milestone for Cr

  • [By Lisa Levin] Gainers
    Vicor Corporation (NASDAQ: VICR) rose 19.7 percent to $35 in pre-market trading. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 13.5 percent to $16.88 in pre-market trading after climbing 104.82 percent on Tuesday.
    Cree, Inc. (NASDAQ: CREE) shares rose 11.3 percent to $43.81 in pre-market trading as the company reported upbeat results for its third quarter on Tuesday.
    The Clorox Company (NYSE: CLX) rose 9.6 percent to $125.98 in pre-market trading.
    Aduro BioTech, Inc. (NASDAQ: ADRO) rose 5.8 percent to $7.25 in pre-market trading after falling 1.44 percent on Tuesday.
    STMicroelectronics N.V. (NYSE: STM) rose 5.2 percent to $22.42 in pre-market trading after reporting Q1 results.
    Twitter, Inc. (NYSE: TWTR) rose 5.2 percent to $32.05 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Credit Suisse Group AG (NYSE: CS) rose 5 percent to $17.11 in pre-market trading following strong Q1 results.
    Harmony Gold Mining Company Limited (NYSE: HMY) shares rose 4.4 percent to $2.02 in pre-market trading.
    22nd Century Group, Inc. (NYSE: XXII) rose 4.9 percent to $2.15 in pre-market trading after dropping 8.07 percent on Tuesday.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.1 percent to $102.40 in pre-market trading after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    iRobot Corporation (NASDAQ: IRBT) rose 3.3 percent to $61 in pre-market trading following upbeat quarterly earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Max Byerly]

    HSBC set a €27.00 ($32.14) price objective on AXA (EPA:CS) in a research report released on Wednesday. The firm currently has a buy rating on the stock.

Top 5 Medical Stocks To Watch For 2018: InfraREIT, Inc.(HIFR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on InfraREIT (HIFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Reaves W H & Co. Inc. trimmed its holdings in InfraREIT (NYSE:HIFR) by 18.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,342,026 shares of the real estate investment trust’s stock after selling 303,392 shares during the quarter. Reaves W H & Co. Inc. owned approximately 3.05% of InfraREIT worth $26,076,000 as of its most recent SEC filing.

Top 5 Medical Stocks To Watch For 2018: MB Financial Inc.(MBFI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    MB Financial (NASDAQ: MBFI) and Nicolet Bankshares (NASDAQ:NCBS) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk.

  • [By Ethan Ryder]

    MB Financial (NASDAQ:MBFI) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a report released on Monday.

Top 5 Medical Stocks To Watch For 2018: Jack Henry & Associates Inc.(JKHY)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Whittier Trust Co. of Nevada Inc. raised its position in Jack Henry & Associates (NASDAQ:JKHY) by 42.5% in the first quarter, Holdings Channel reports. The fund owned 3,154 shares of the technology company’s stock after buying an additional 940 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Jack Henry & Associates were worth $381,000 as of its most recent SEC filing.